Loading

JSM Communication Disorders

Making Intensive Voice Treatment (LSVT® LOUD) Accessible for a Child With Autism Spectrum Disorder (ASD) and Mixed Dysarthria Using a Novel, Pre-Treatment Protocol

Case Report | Open Access | Volume 4 | Issue 1

  • 1. NYU Grossman School of Medicine, New York, New York, United States
  • 2. Open Lines Speech and Communication PLLC, New York, New York, United States
  • 3. 3 Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, New York, United States
  • 4. National Center for Voice and Speech, Denver, Colorado, United States
  • 5. Department of Speech-Language and Hearing Sciences, University of Colorado, Boulder, Colorado, United States
  • 6. LSVT Global, Inc., Tucson, Arizona, United States
+ Show More - Show Less
Corresponding Authors
Jessica Galgano, Open Lines Speech and Communication, 252 West 76th Street Suite 1A, New York, NY 10023, United States
Abstract

Although motor speech disorders (dysarthria, apraxia) are not currently considered core symptoms of autism spectrum disorder (ASD), reviews of clinical reports reveal a significant prevalence of these disorders among children with ASD. This report examines implementation of LSVT® LOUD, an established intensive treatment protocol developed originally for individuals with hypokinetic dysarthria secondary to Parkinson’s disease and recently successfully applied to children, in the treatment of a child with dysarthria and ASD. Because this child was initially deemed unstimulable for intensive treatment, a novel pre-treatment protocol was implemented. Following the pre-treatment protocol, outcomes resulted in significant immediate and long-term gains in multiple parameters of functional communication. This report supports consideration of a pre-treatment protocol before intensive interventions such as LSVT LOUD.

Keywords

Autism Spectrum Disorder (ASD); LSVT® LOUD Dysarthria; Pediatric speech treatment; Intensive speech treatment.

Citation

Galgano J, Yan Tsang GJ, Ramig LA (2021) Making Intensive Voice Treatment (LSVT® LOUD) Accessible for a Child With Autism Spectrum Disorder (ASD) and Mixed Dysarthria Using a Novel, Pre-Treatment Protocol. JSM Communication Dis 4(1): 1013.

ABBREVIATIONS

ASD: Autism Spectrum Disorder, LSVT® LOUD: Lee Silverman Voice Treatment, MSVP: Maximum sustained vowel phonation, SPL: Sound pressure level, LSVT: Lee Silverman Voice Treatment, s: Seconds, dB: Decibel, Hz: Hertz

INTRODUCTION

Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder observed in childhood characterized in part by deficits in perspective-taking, social interaction, cognitive-communication, and sensorimotor integration.(1) Although motor symptoms are not currently considered core symptoms of ASD, reviews of clinical reports show motor delays and impairments, such as hypotonia, dyspraxia, and oromotor deficits, are highly prevalent in this population. (2-4) Although consistent prevalence figures are not documented, Shriberg (3) estimated that a substantial portion of children with neurodevelopmental disorders such as ASD have comorbid motor speech disorders. Among the 47.7% of children with concurrent neurodevelopmental disorders and motor speech delays, 13.3% were diagnosed with dysarthria and 4.9% were diagnosed with dysarthria and Childhood Apraxia of Speech (CAS). As a result, children with ASD may experience a wide range of speech, voice, and prosodic deficits in addition to more commonly reported disorders in language.(2,5,6) While speechlanguage pathologists (SLPs) are familiar with therapies to address the cognitive-communication challenges this population faces, treatments for managing motor speech disorders within the ASD population remain scant.

Dysarthria in the ASD population is characterized by lower vocal fundamental frequencies (F0), higher vowel formant frequencies, reduced maximum phonation times (MPT), reduced variation in speech duration and speech loudness (i.e., average sound pressure level (SPL) and difficulty with loudness control), and greater variability in lexical stress ratios.(5,6) Disordered articulation has also been described in these children, though it is challenging to determine the contribution of dysarthria in these impairments, as the majority of research within this category focuses on the symptoms and prevalence of CAS.6 Consequently, to our knowledge, effective intensive motor speech treatment approaches in pediatric dysarthria for people with ASD have not been explored.

A speech treatment protocol known as LSVT LOUD has a significant amount of documented efficacy for the treatment of hypokinetic dysarthria secondary to Parkinson’s disease (PD) (7- 10) and also has been shown to be effective in the management of pediatric dysarthria secondary to cerebral palsy and Down syndrome. Existing literature on the efficacy of LSVT LOUD as a treatment option for pediatric dysarthria has been promising, with researchers reporting positive outcomes in acoustic measures and listener perception. (11-15)

LSVT LOUD is unique in a number of ways. It uses a single treatment target of healthy loudness as a trigger for a wide distribution of effects across the entire motor speech production system. (10) Post-treatment improvements have been documented in respiratory kinematics, electromyography (EMG) activity, vocal fold closure, acoustic measures (e.g., MPT, vocal SPL, fundamental frequency variability, articulatory precision), listener perception variables (e.g., voice quality), speech intelligibility and language function.(16) A single treatment target with limited cognitive complexity resulting in distributed effects offers a potentially viable treatment option for people with dysarthria and ASD (Figure 1). (7-10, 17, 18) LSVT LOUD adheres to principles of motor learning and activity dependent neuroplasticity, such as intensity of practice, repetition, saliency of materials and activities used, performance accuracy and specificity of training. It is delivered in an intensive dosage (16, one-hour sessions, four days per week for one month) with a high effort mode of delivery both within and across treatment sessions. (8-11, 19) It teaches target behaviors via modeling and a verbal cue for loudness, resulting in an increase is overall amplitude of movement and subsequent normal though greater than baseline loudness levels. This intensive dosage is in contrast to traditional treatment paradigms, which are less intensive and provide verbal instruction for multiple targets. LSVT LOUD also addresses sensory processing and internal cueing deficits that limit learning and generalization into functional speech production (10),which may be relevant in the ASD population.

Figure 1 Schematic showing spreading effects of healthy vocal loudness across the speech mechanism. Permission granted by LSVT Global, Inc.

Figure 1 Schematic showing spreading effects of healthy vocal loudness across the speech mechanism. Permission granted by LSVT Global, Inc.

Importantly, the treatment target trained in LSVT LOUD is elicited through modeling target behaviors, which children with autism are responsive to and which minimizes explicit verbal instructions (20), allowing a child’s system to implicitly self-organize to achieve a goal. (21) Further, the use of a singular training target, which reduces cognitive load, may result in a greater chance of compliance during treatment and of improvements in communicative competence and speech with autism are responsive to and which minimizes explicit verbal instructions (20), allowing a child’s system to implicitly self-organize to achieve a goal. (21) Further, the use of a singular training target, which reduces cognitive load, may result in a greater chance of compliance during treatment and of improvements in communicative competence and speech

Previous studies have documented children with autism are capable of intensive behavioral and speech treatment regimens. (22, 23) Research has also shown that the use of task-specific, repetitive, and active practice with increased numbers of practice trials results in marked improvements across several domains (22, 23) in children with autism. This suggests they may be able to participate in and benefit from an intensive mode of treatment utilizing a specific treatment target and repetitive, active practice. As such, LSVT LOUD has the potential to be a valuable treatment for pediatric dysarthria.

Despite the potential benefits of choosing LSVT LOUD for speakers with pediatric dysarthria and ASD, some of these children who have the potential to benefit from it may not be immediately ready for intensive motor speech intervention. However, to our knowledge, there are no reports detailing specific protocols or criteria that could be used to prepare a child for participation in this type of intensive intervention program. Thus, there is a need for a pre-treatment protocol to prepare these children to have access to the benefits of an intensive dosage of LSVT LOUD.

In the context of this report, adaptations and supports needed for a child with ASD and mixed dysarthria initially deemed unable to participate in an intensive treatment protocol are examined and documented. A pre-treatment protocol was administered for 18 months to ultimately prepare the child to receive LSVT LOUD. This report describes the use of this novel pre-treatment protocol, which permitted learning of the exercises within the LSVT LOUD protocol and make gains in overall loudness (SPL) and intelligibility for improved communicative effectiveness.

 

CASE PRESENTATION

Participant

At the onset of this intervention, the child was a 16.5-year-old male. Medical diagnoses provided by a pediatric developmental neurologist included ASD and severe mixed dysarthria. Historical speech and language diagnoses included significant cognitive, language, and sensorimotor disorders, as well as a history of CAS. He received 14 years of traditional speech treatment, which primarily focused on the production of selected phonemes and word approximations to address CAS and incorporated a variety of language-based approaches provided with a low treatment dosage.

Upon intake, primary verbal communication characteristics consisted mainly of single word and rote phrase approximations. The speech diagnosis of mixed dysarthria and the severity of the speech disorder (severe) were determined by consensus by three SLPs through audio samples and interview. (24-26) Results of standardized and informal assessment measures and observed speech and voice characteristics revealed severe dysarthria, characterized by reduced strength, range of motion, speed, and coordination of oral motor structures, resulting in reduced articulatory accuracy, MPT, loudness and pitch ranges in maximum performance tasks and in speech, lexical stress ratios, breath support and control, and intelligibility of attempted utterances. In addition, a monotone intonation pattern, fast rate, output limited to word or short phrase approximations, imprecise articulation, dysfluencies and prosodic abnormalities were noted. At the time of the initial assessment and stimulability testing, the child was unable to volitionally inhale despite models or cues and was unable to consistently respond to cues to increase loudness. Maximum sustained vowel phonation was <1s with amplitude levels of vowels and speech approximations were <50db SPL at a 30 cm microphone to mouth distance. This, in addition to physical and behavioral challenges that impacted his tolerance for repeated daily practice and intensive intervention, resulted in a lack of stimulability or candidacy for the program. However, the parent and child expressed a great desire to attempt to participate in the intensive program. Therefore, a pre-treatment protocol consisting of a less intensive series of steps that built skills in a hierarchical manner and in preparation for the intensity of practice needed for LSVT LOUD was trialed ( Figure. 2).

Figure 2 Schematic showing overall therapeutic timeline from pre-treatment protocol design, pre-treatment protocol delivery, pre-LSVT LOUD assessment, intensive LSVT LOUD treatment, post LSVT LOUD assessment, to follow-up LSVT LOUD assessment.

Figure 2 Schematic showing overall therapeutic timeline from pre-treatment protocol design, pre-treatment protocol delivery, pre-LSVT LOUD assessment, intensive LSVT LOUD treatment, post LSVT LOUD assessment, to follow-up LSVT LOUD assessment.

Figure 3 Schematic showing pre-treatment design, including pre-treatment protocol specifications at 0-6 months, 6-12 months, and 12-18 months

Figure 3: Schematic showing pre-treatment design, including pre-treatment protocol specifications at 0-6 months, 6-12 months, and 12-18 months.

Procedures

An 18-month, pre-treatment protocol in the form of low dose, low frequency treatment that gradually increased in sessions per week and intensity within sessions was prescribed to develop an increased tolerance for specific speech motor exercises. The pretreatment protocol was administered in three stages, each lasting six months.

Goals for stage 1 for the pre-treatment protocol (zero-tosix-months) focused on establishing a response to multisensory models to be able to establish volitional inhalation, deepen inhalation, and sustain exhalation; pair phonation with exhalation; build tolerance for repetitive practice and establish behavioral supports; and establish strategies to increase compliance and attention. Through a multisensory approach and gradual faded cueing presented within a repetitive mode of practice, the child could volitionally inhale, exhale and sustain exhalation in response to visual cues. Once the coordinated movement of inhalation and exhalation was established, the goal became to pair sustained exhalation with phonation, thus beginning to move the coordinated movement pattern of inhalation and exhalation into speech production. To address behavioral concerns, the SLP collaborated with the child’s caregivers to establish supports and develop strategies for continued improvement. Breaks in motor practice, longer sessions to accommodate movement breaks, increased reinforcement and behavioral counseling were utilized at this stage for support.

Goals for stage two of the pre-treatment protocol (6-12 months) focused on stabilizing healthy phonation of normal loudness, extending phonation duration, and teaching pitch manipulation while maintaining normal loudness and developing the endurance to complete 15 repetitions of each of two daily voice exercises (i.e., 15 repetitions of Maximum Duration Sustained Vowel Phonation; 15 repetitions of High Ah; 15 repetitions of Low Ah) designated by the LSVT LOUD protocol, within 25 minutes.

Goals for stage three of the pre-treatment protocol (12-18 months) were centered around developing endurance to read of a list of ten functional phrases within five minutes and implement scaled up, normal loudness levels in hierarchical language exercises for an additional 25 minutes (i.e., words, phrases, sentences, and supported conversation), with dual tasking added when appropriate. Once competency in performing all aspects of the program was established in under an hour, candidacy for the intensive LSVT LOUD protocol was confirmed.

The LSVT LOUD protocol was then administered. A summary of key LSVT LOUD treatment elements is provided (Table 1). For a full description of the treatment protocol, please see.(10)

Table 1: LSVT LOUD treatment protocol.

LSVT LOUD

Focus of treatment

Healthy Vocal Loudness

Dosage

Increased movement amplitude directed

predominately to respiratory-laryngeal systems

Individual treatment session of 1 hour, 4 consecutive days per week over a 4-week period

Effort

Push for participant perceived effort

LSVT LOUD Daily Exercises

• Maximum sustained movements completing multiple repetitions of tasks, minutes 1-12

 • Directional movements completing multiple repetitions of tasks, minutes 13-23

• Functional movements, minutes 24-30

Sustain the vowel “ah” in a good-quality, loud voice, for as long as possible

Say the vowel “ah” in a good-quality, loud voice

gliding high in pitch; hold for 5 seconds

Say the vowel “ah” in a good-quality, loud voice

gliding low in pitch; hold for 5 seconds

Participant reads 10 self-generated phrases he/she says daily in functional living (e.g., “Good morning”) using the same effort and loudness as he/she did during the maximum sustained movements exercise

LSVT LOUD Hierarchy Exercises, minutes 31-55 Purpose

Method

Exercises

• Train rescaled vocal loudness achieved in the Daily Exercises into context-specific and variable speaking activities

• Incorporate multiple repetitions of reading and conversation tasks with a focus on vocal loudness

• Exercises increase in length of utterance and difficulty across weeks, progressing from words to phrases to sentences to reading to conversation, and can be tailored to each participant’s goals (e.g., communicate at work or with caregivers) and interests (e.g., speak on topics of golf, cooking)

Assign Homework Exercises to be completed outside of the therapy room, minutes 56-60

Duration and repetitions on treatment days (4 days/week)

Duration and repetitions on nontreatment days (3 days/week)

Conversational Carryover Assignment Difficulty level

• Subset of the Daily Exercises and Hierarchy Exercises; 10 minutes, performed once per day

• Subset of the Daily Exercises and Hierarchy Exercises; 15 minutes, performed twice per day

• Participant is to use the louder voice practiced in exercises in a real-world communication situation

• Matched to the level of the hierarchy where the participant is in treatment

Shaping techniques

Purpose and approach

• Train vocal loudness that is healthy and within normal limits (i.e., no unwanted vocal strain) through use of modeling (“do what I do”) or tactile/visual cues

Sensory calibration

 • Focus attention on how it feels and sounds to talk with increased vocal loudness (self-monitoring) and to internally cue (self-generate) new loudness effort in speech

Objective and subjective clinical data collected during each treatment session

• Measures of duration, frequency, and sound pressure level

• Documentation of percentage of cueing required to implement vocal loudness strategy

• Observations of perceptual voice quality

• Participant’s self-reported comments about successful use of the improved loudness in daily communication

• Participant self-reported perceived effort

Abbreviations: LSVT®: Lee Silverman Voice Treatment

Data Collection

Acoustic and perceptual testing and a motor speech examination were completed prior to beginning, immediately following, and five months post LSVT LOUD. Acoustic samples were collected using a SPL meter at a consistent microphone to mouth distance of 30cm from session to session. Six repetitions of each task were collected at each session and mean values were used to reflect maximum sustained vowel phonation (MSVP), maximum phonation frequency range (MPFR), and maximum sound pressure level (MSPL) in a sustained vowel, and MSPL in speech. The functional impact of treatment upon communication was assessed by gathering perceptual data from the parent, caregiver and child. A visual analog scale (27,28) was used to rate 10 variables of speech, voice, and spoken communication. 

Significant improvements were noted in acoustic measures from the time of the initial assessment completed prior to administration of the pre-treatment protocol through testing before and after LSVT LOUD. Following the pre-treatment protocol, the child had demonstrated the ability to learn and follow through with the LSVT LOUD intensive protocol. Significant improvements in acoustic measures collected at a 30cm microphone to mouth distance were noted, including MSVP, SPL of a sustained vowel, and SPL in speech phrases. All tasks were repeated six times. No improvements were made in highest or lowest maximum F0 range. Overall improvements were noted for speech and intelligibility, though variability due to behavior and cognitive-communication disorder was noted. Gains were maintained five-months post treatment, with improvements in all four areas and a significant increase in MSVP (Table 2). Previous disfluencies contributing to unintelligibility were absent during post-testing and follow-up.

Table 2: Initial Assessment, Post Pre-Treatment Protocol, Pre-Post and five-month Follow-up LSVT LOUD data for maximum duration sustained vowel phonation, vocal sound pressure level for sustained vowels, vocal sound pressure level for speech phrases, highest maximum fundamental frequency and lowest fundamental frequency and maximum fundamental frequency range.

Measure

Initial Assessment

Post Pre[1]Treatment Protocol

Pre-LSVT LOUD

Post-LSVT LOUD

Follow-up

M

SD

M

SD

M

SD

M

SD

M

SD

Maximum sustained vowel phonation (MSVP) (s)

0.50

0.55

1.88

0.35

2.72

0.62

8.51

2.59

12.98

1.41

Vocal sound pressure level (SPL) of a sustained vowel (dB)a

40.00

0.00

70.64

1.19

73.37

2.57

84.92

0.86

85.50

1.00

Vocal sound pressure level (SPL) of speech (dB)a

45.00

7.07

45.00

7.07

48.10

11.03

69.00

9.90

70.50

7.78

Highest maximum fundamental frequency range (Hz)b

-

-

320.00

96.12

367.17

96.27

293.83

75.14

304.17

12.06

Lowest maximum fundamental frequency range (Hz)b

-

-

200.83

32.12

191.17

42.89

155.5

10.05

160.00

6.66

Abbreviations: MSVP: Maximum sustained vowel phonation; SPL: Sound pressure level; LSVT: Lee Silverman Voice Treatment; s: Seconds; dB: Decibel; Hz: Hertz

Both the parent and child reported improvements in “breathing associated with speech, speech intelligibility and initiation and participation in a conversation.” The child also reported improvements in ease of speech production, an ability to breathe and control speech, and confidence speaking with individuals.

DISCUSSION

In conclusion, LSVT LOUD was found to be successful in producing significant gains across acoustic and perceptual variables and in improving multiple parameters of functional communication in a child with dysarthria and ASD. More importantly, improvements were maintained, as reflected in post-testing at the five-month timepoint. Given significant improvements evidenced despite initial testing showing lack of stimulability, this report motivates serious consideration of appropriate pre-treatment protocols to allow more children to benefit from LSVT LOUD and other intensive interventions. Currently, those who do not immediately show signs of stimulability, who are unable to follow behavioral models or cues and who are unable to commit to intensive treatment, either physically or mentally, are not considered candidates for LSVT LOUD. An individualized pre-treatment protocol would permit children to be reached and benefit from intensive programs even when not immediately ready to participate at the time of the initial assessment and stimulability testing session.

The findings of this case report are significant as they are the first, to our knowledge, to use an evidenced-based, intensive treatment, LSVT LOUD, to treat motor-speech disorders among the ASD population. This report also documents the first case, to our knowledge, to implement a novel pre-treatment protocol for a child who was not initially eligible for an intensive treatment protocol, but who ultimately benefitted from the completion of it. While research continues to support the efficacy of intensive treatment, some children are prevented from receiving it given cognitive, physical or behavioral challenges. This case is a preliminary step in addressing ways clinicians can make LSVT LOUD accessible for a greater number of children. Much further study is necessary regarding treatment of pediatric dysarthria, especially among the ASD population. This case report illustrates a need for researchers to study how clinicians can accommodate the comorbid conditions that this and other populations may face through use of a pre-treatment protocol which can allow more children to access the benefits of LSVT LOUD and other intensive interventions.

ACKNOWLEDGEMENTS

We sincerely thank Brianna Rogers, Emily Bakker and Ona Reed for their help with the initial and final steps of manuscript preparation.

CONFLICTS OF INTEREST

Jessica Galgano’s affiliations include Open Lines Speech and Communication PLLC in New York, New York, NYU Grossman School of Medicine in New York, New York, and LSVT Global, Inc. in Tucson, Arizona. Grace Ji Yan Tsang is affiliated with Open Lines Speech and Communication PLLC in New York, New York. Lorraine A. Ramig is affiliated with the Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, New York, National Center for Voice and Speech, Denver, Colorado, Department of Speech-Language and Hearing Sciences, University of Colorado, Boulder, Colorado, and LSVT Global, Inc., Tucson, Arizona.

REFERENCES

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, D. C: American Psychiatric Association. 2013.

2. Ming X, Brimacombe M, Wagner GC Prevalence of motor impairment in autism spectrum disorders. Brain Dev. 2007; 29: 565-570.

3. Shriberg LD, Strand EA, Jakielski KJ, Mabie HL. Estimates of the prevalence of speech and motor speech disorders in persons with complex neurodevelopmental disorders. Clin Linguist Phon. 2019; 33: 707-736.

4. Bhat AN. Is motor impairment in autism spectrum disorder distinct from developmental coordination disorder? A report from the SPARK study. Physical Therapy. 2020; 100: 633-644.

5. Velleman SL, Andrianopoulos MV, Boucher M, Perkins J, Averback K et. al. Motor Speech disorders in children with autism. In: Paul, R, Flipsen, P, editors. Speech sound disorders in children. San Diego, CA: Plural Publishing. 2009; 141-180.

6. Shriberg LD, Paul R, Black LM, Van Santen JP. The hypothesis of apraxia of speech in children with autism spectrum disorder. J Autism Dev Disord. 2011; 41: 405-426.

7. Levy ES, Moya-Galé G, Chang YHM, Freeman K, Forrest K, Brin MF et. al. The effects of intensive speech treatment on intelligibility in Parkinson’s disease: A randomised controlled trial. EClinicalMedicin. 2020; 24: 1-11.

8. Ramig LO, Sapir S, Countryman S, Pawlas AA, O’Brien C, Hoehn M et al. Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: A 2 year follow up. J Neurol Neurosurg Psychiatry. 2001; 71: 493-498. 

9. Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson’s disease: A comparison with untreated patients and normal age?matched controls. Mov Disord. 2001; 16: 79-83.

10. Ramig L, Halpern A, Spielman J, Fox C, Freeman K. Speech treatment in Parkinson’s diseas: Randomized controlled trial (RCT e). Mov Disord. 2018; 33: 1777-1791.

11. Fox CM, Boliek CA. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. J Speech Lang Hear Res. 2012; 55: 930-945.

12. Levy ES, Ramig LO, Camarata SM. The effects of two speech interventions on speech function in pediatric dysarthria. Journal of Medical Speech-Language Pathology. 2013; 20: 82–87.

13. Levy ES. Implementing two treatment approaches to childhood dysarthria. Int J Speech Lang Pathol. 2014; 16: 344–354.

14. Boliek CA, Fox CM. Therapeutic effects of intensive voice treatment (LSVT LOUD®) for children with spastic cerebral palsy and dysarthria: A protocol I treatment validation study. Int J Speech Lang Pathol. 2017; 19: 601–615.

15. Reed A, Cummine J, Bakhtiari R, Fox CM, Boliek CA. Changes in white matter integrity following intensive voice treatment (LSVT LOUD®) in children with cerebral palsy and motor speech disorders. Dev Neurosci. 2017; 39: 460–471.

16. Mahler LA, Ramig LO, Fox C. Evidence-based treatment of voice and speech disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg. 2015; 23: 209–215.

17. Sapir S, Spielman JL, Ramig LO, Story BH, Fox CM. Effects of intensive voice treatment (the Lee Silverman voice treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual finings. J Speech Lang Hear Res. 2007; 50: 899-912.

18. Ramage A, Fox C, Halpern A, Ramig L. Improved verb use in Parkinson’s disease following intensive voice treatment. Movement Disorder Society Virtual Congress. 2020: 35.

19. Boliek CA, Fox CM. Individual and environmental contributions to treatment outcomes following a neuroplasticity-principled speech treatment (LSVT LOUD) in children with dysarthria secondary to cerebral palsy: A case study review. Int J Speech Lan Pathol. 2014; 16: 372-385.

20. Rogers SJ, Hayden D, Hepburn S, Charlifue-Smith R, Hall T, Hayes A. Teaching young nonverbal children with autism useful speech: A pilot study of the Denver model and PROMPT interventions. J of Autism Dev Disord. 2006; 36: 1007-1024.

21. Schmidt RC, Fitzpatrick P. Dynamical perspective on motor learning. In H. Zelaznik (Ed.) Advances in Motor Learning and Control. Champaign, IL: Human Kinetics. 1996; 195-223.

22. Eikeseth S, Smith T, Jahr E, Eldevik S. Intensive behavioral treatment at school for 4-to 7-year-old children with autism: A 1-year comparisoncontrolled study. Behav modif. 2002; 26: 49-68.

23. Wan CY, Bazen L, Baars R, Libenson A, Zipse L, Zuk J et. al. Auditorymotor mapping training as an intervention to facilitate speech output in non-verbal children with autism: A proof of concept study. PloS one. 2011; 6: e2550

24. Fox CM, Boliek CA. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. J Speech Lang Hear Res. 2012; 55: 930-945.

25. Levy ES, Chang YM, Ancelle JA, McAuliffe MJ. Acoustic and perceptual consequences of speech cues for children with dysarthria. J Speech Lang Hear Res. 2017; 60: 1766-1779.

26.  McAuliffe MJ, Kerr SE, Gibson EM, Anderson T, LaShell PJ. Cognitive– perceptual examination of remediation approaches to hypokinetic dysarthria. J Speech Lang Hearg Res. 2014; 57: 1268-1283.

27. Kempster G. A multidimensional analysis of vocal quality in two dysphonic groups [dissertation]. Evanston (IL): Northwestern University. 1984.

28. Schiffman SS, Reynolds ML, Young FW. Introduction to multidimensional scaling. 1st Edn. New York: Academic Press. 1981

Galgano J, Yan Tsang GJ, Ramig LA (2021) Making Intensive Voice Treatment (LSVT® LOUD) Accessible for a Child With Autism Spectrum Disorder (ASD) and Mixed Dysarthria Using a Novel, Pre-Treatment Protocol. JSM Communication Dis 4(1): 1013.

Received : 19 Jul 2021
Accepted : 10 Aug 2021
Published : 13 Aug 2021
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X